{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T03:02:57Z","timestamp":1784862177341,"version":"3.55.0"},"reference-count":30,"publisher":"Spandidos Publications","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,3]]},"DOI":"10.3892\/ijo.2013.1793","type":"journal-article","created":{"date-parts":[[2013,1,23]],"date-time":"2013-01-23T11:30:25Z","timestamp":1358940625000},"page":"831-838","source":"Crossref","is-referenced-by-count":18,"title":["Identification of an H2-Kb or H2-Db restricted and glypican-3-derived cytotoxic T-lymphocyte epitope peptide"],"prefix":"10.3892","volume":"42","author":[{"given":"TATSUAKI","family":"IWAMA","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"KAZUTAKA","family":"HORIE","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"TOSHIAKI","family":"YOSHIKAWA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"DAISUKE","family":"NOBUOKA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MANAMI","family":"SHIMOMURA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"YU","family":"SAWADA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"TETSUYA","family":"NAKATSURA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2013,1,23]]},"reference":[{"key":"key20180107180829_b1-ijo-42-03-0831","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3322\/caac.20107","article-title":"Global cancer statistics","volume":"61","author":"Jemal","year":"2011","journal-title":"CA Cancer J Clin"},{"key":"key20180107180829_b2-ijo-42-03-0831","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1053\/jhep.2001.27950","article-title":"Treatment strategy for small hepatocellular carcinoma: comparison of long-term results after percutaneous ethanol injection therapy and surgical resection","volume":"34","author":"Yamamoto","year":"2001","journal-title":"Hepatology"},{"key":"key20180107180829_b3-ijo-42-03-0831","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/j.jhep.2006.09.004","article-title":"Immunotherapy of hepatocellular carcinoma","volume":"45","author":"Greten","year":"2006","journal-title":"J Hepatol"},{"key":"key20180107180829_b4-ijo-42-03-0831","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1158\/0008-5472.CAN-05-2090","article-title":"Embryonic stem cell-derived dendritic cells expressing glypican-3, a recently identified oncofetal antigen, induce protective immunity against highly metastatic mouse melanoma, B16-F10","volume":"66","author":"Motomura","year":"2006","journal-title":"Cancer Res"},{"key":"key20180107180829_b5-ijo-42-03-0831","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1002\/hep.24149","article-title":"Comparative analysis of various tumor-associated antigen-specific T-cell responses in patients with hepatocellular carcinoma","volume":"53","author":"Mizukoshi","year":"2011","journal-title":"Hepatology"},{"key":"key20180107180829_b6-ijo-42-03-0831","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1158\/1078-0432.CCR-05-2856","article-title":"A phase I\/II trial testing immunization of hepatocellular carcinoma patients with dendritic cells pulsed with four alpha-fetoprotein peptides","volume":"12","author":"Butterfield","year":"2006","journal-title":"Clin Cancer Res"},{"key":"key20180107180829_b7-ijo-42-03-0831","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1186\/1471-2407-10-209","article-title":"A phase II open label trial evaluating safety and efficacy of a telomerase peptide vaccination in patients with advanced hepatocellular carcinoma","volume":"10","author":"Greten","year":"2010","journal-title":"BMC Cancer"},{"key":"key20180107180829_b8-ijo-42-03-0831","first-page":"5902","article-title":"T-cell responses to HLA-A*0201 immunodominant peptides derived from alpha-fetoprotein in patients with hepatocellular cancer","volume":"9","author":"Butterfield","year":"2003","journal-title":"Clin Cancer Res"},{"key":"key20180107180829_b9-ijo-42-03-0831","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/S0006-291X(03)00908-2","article-title":"Glypican-3, over-expressed specifically in human hepatocellular carcinoma, is a novel tumor marker","volume":"306","author":"Nakatsura","year":"2003","journal-title":"Biochem Biophys Res Commun"},{"key":"key20180107180829_b10-ijo-42-03-0831","doi-asserted-by":"crossref","first-page":"6245","DOI":"10.1158\/0008-5472.CAN-04-4244","article-title":"Glypican-3 promotes the growth of hepatocellular carcinoma by stimulating canonical Wnt signaling","volume":"65","author":"Capurro","year":"2005","journal-title":"Cancer Res"},{"key":"key20180107180829_b11-ijo-42-03-0831","doi-asserted-by":"crossref","first-page":"R19","DOI":"10.1093\/glycob\/11.3.19R","article-title":"Glypicans in growth control and cancer","volume":"11","author":"Filmus","year":"2001","journal-title":"Glycobiology"},{"key":"key20180107180829_b12-ijo-42-03-0831","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1186\/gb-2008-9-5-224","article-title":"Glypicans","volume":"9","author":"Filmus","year":"2008","journal-title":"Genome Biol"},{"key":"key20180107180829_b13-ijo-42-03-0831","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.1158\/1078-0432.CCR-05-2267","article-title":"Identification of HLA-A2-or HLA-A24-restricted CTL epitopes possibly useful for glypican-3-specific immunotherapy of hepatocellular carcinoma","volume":"12","author":"Komori","year":"2006","journal-title":"Clin Cancer Res"},{"key":"key20180107180829_b14-ijo-42-03-0831","doi-asserted-by":"crossref","first-page":"8630","DOI":"10.1158\/1078-0432.CCR-04-1177","article-title":"Mouse homologue of a novel human oncofetal antigen, glypican-3, evokes T-cell-mediated tumor rejection without autoimmune reactions in mice","volume":"10","author":"Nakatsura","year":"2004","journal-title":"Clin Cancer Res"},{"key":"key20180107180829_b15-ijo-42-03-0831","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.4161\/onci.21351","article-title":"A glypican-3-derived peptide vaccine against hepatocellular carcinoma","volume":"1","author":"Sawada","year":"2012","journal-title":"Oncoimmunology"},{"key":"key20180107180829_b16-ijo-42-03-0831","doi-asserted-by":"crossref","first-page":"3686","DOI":"10.1158\/1078-0432.CCR-11-3044","article-title":"Phase I trial of a glypican-3-derived peptide vaccine for advanced hepatocellular carcinoma: immunologic evidence and potential for improving overall survival","volume":"18","author":"Sawada","year":"2012","journal-title":"Clin Cancer Res"},{"key":"key20180107180829_b17-ijo-42-03-0831","article-title":"Intratumoral peptide injection enhances tumor cell antigenicity recognized by cytotoxic T lymphocytes: a potential option for improvement in antigen-specific cancer immunotherapy","author":"Nobuoka","year":"2012","journal-title":"Cancer Immunol Immunother"},{"key":"key20180107180829_b18-ijo-42-03-0831","first-page":"985","article-title":"HLA-A2 and -A24-restricted glypican-3-derived peptide vaccine induces specific CTLs: preclinical study using mice","volume":"32","author":"Motomura","year":"2008","journal-title":"Int J Oncol"},{"key":"key20180107180829_b19-ijo-42-03-0831","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1002\/hep.1840190403","article-title":"High-level expression of hepatitis B virus HBx gene and hepatocarcinogenesis in transgenic mice","volume":"19","author":"Koike","year":"1994","journal-title":"Hepatology"},{"key":"key20180107180829_b20-ijo-42-03-0831","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1099\/0022-1317-78-7-1527","article-title":"Hepatitis C virus core protein induces hepatic steatosis in transgenic mice","volume":"78","author":"Moriya","year":"1997","journal-title":"J Gen Virol"},{"key":"key20180107180829_b21-ijo-42-03-0831","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1111\/j.1349-7006.2008.01016.x","article-title":"Identification of the H2-Kd-restricted cytotoxic T lymphocyte epitopes of a tumor-associated antigen, SPARC, which can stimulate antitumor immunity without causing autoimmune disease in mice","volume":"100","author":"Ikuta","year":"2009","journal-title":"Cancer Sci"},{"key":"key20180107180829_b22-ijo-42-03-0831","doi-asserted-by":"crossref","first-page":"176","DOI":"10.3109\/08916934.2011.622014","article-title":"Prediction of HLA class I-restricted T-cell epitopes of islet autoantigen combined with binding and dissociation assays","volume":"45","author":"Wu","year":"2012","journal-title":"Autoimmunity"},{"key":"key20180107180829_b23-ijo-42-03-0831","first-page":"1041","article-title":"Identification of an HLA-A*0201-restricted cytotoxic T lymphocyte epitope from the lung carcinoma antigen, Lengsin","volume":"39","author":"Nakatsugawa","year":"2011","journal-title":"Int J Oncol"},{"key":"key20180107180829_b24-ijo-42-03-0831","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1002\/eji.200839098","article-title":"Identification and characterization of survivin-derived H-2Kb-restricted CTL epitopes","volume":"39","author":"Hofmann","year":"2009","journal-title":"Eur J Immunol"},{"key":"key20180107180829_b25-ijo-42-03-0831","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1002\/eji.1830230810","article-title":"TAP2-defective RMA-S cells present Sendai virus antigen to cytotoxic T lymphocytes","volume":"23","author":"Zhou","year":"1993","journal-title":"Eur J Immunol"},{"key":"key20180107180829_b26-ijo-42-03-0831","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1002\/eji.1830240341","article-title":"Identification of wild-type and mutant p53 peptides binding to HLA-A2 assessed by a peptide loading-deficient cell line assay and a novel major histocompatibility complex class I peptide binding assay","volume":"24","author":"Stuber","year":"1994","journal-title":"Eur J Immunol"},{"key":"key20180107180829_b27-ijo-42-03-0831","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/1479-5876-7-44","article-title":"HLA-A*0201-restricted CTL epitope of a novel osteosarcoma antigen, papillomavirus binding factor","volume":"7","author":"Tsukahara","year":"2009","journal-title":"J Transl Med"},{"key":"key20180107180829_b28-ijo-42-03-0831","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1111\/j.1349-7006.2011.01896.x","article-title":"HLA-A2-restricted glypican-3 peptide-specific CTL clones induced by peptide vaccine show high avidity and antigen-specific killing activity against tumor cells","volume":"102","author":"Yoshikawa","year":"2011","journal-title":"Cancer Sci"},{"key":"key20180107180829_b29-ijo-42-03-0831","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1097\/MPA.0b013e31821ad8d1","article-title":"Identification of HLA-A*0201- and A*2402-restricted epitopes of mucin 5AC expressed in advanced pancreatic cancer","volume":"40","author":"Yamazoe","year":"2011","journal-title":"Pancreas"},{"key":"key20180107180829_b30-ijo-42-03-0831","doi-asserted-by":"crossref","first-page":"107","DOI":"10.4149\/av_2011_02_107","article-title":"Identification and functional studies of HLA-A0201 restricted CTL epitopes in the X protein of hepatitis B virus","volume":"55","author":"Guo","year":"2011","journal-title":"Acta Virologica"}],"container-title":["International Journal of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/ijo.2013.1793\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,1,7]],"date-time":"2018-01-07T18:10:55Z","timestamp":1515348655000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/ijo.2013.1793"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1,23]]},"references-count":30,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2013,1,23]]},"published-print":{"date-parts":[[2013,3]]}},"alternative-id":["10.3892\/ijo.2013.1793"],"URL":"https:\/\/doi.org\/10.3892\/ijo.2013.1793","relation":{},"ISSN":["1019-6439","1791-2423"],"issn-type":[{"value":"1019-6439","type":"print"},{"value":"1791-2423","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,1,23]]}}}